Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

NCT01739244 is registered in ClinicalTrials.gov with Sylentis, S.A. as lead sponsor.

NCT NCT01739244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01739244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Lead sponsor
Sylentis, S.A.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2012
Completion date
May 31, 2013
Enrollment
80 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, open angle glaucoma